Brief: Ono Pharma Chairman Says Seeking Additional Acquisition Targets In U.S. In 100 Billion Yen Range - Nikkei
06/08/2024 09:25
Aug 6 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* ONO PHARMA CHAIRMAN SAYS SEEKING ADDITIONAL ACQUISITION
TARGETS
IN U.S. IN 100 BILLION YEN RANGE - NIKKEI
Source text for Eikon: ID:
Further company coverage: 4528.T
(Reporting by Rocky Swift)
((rocky.swift@thomsonreuters.com;))
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours